Acknowledging the rarity of such a step, U.S. District Chief Judge Colleen McMahon of the Southern District of New York said she was compelled to break with a U.S. magistrate judge's recommendation to allow an expert to testify in a suit over Alzheimer's drugs.

“This is the rare case where I conclude that Magistrate Judge [James] Francis committed clear error by recommending that the Jaskot motion be denied,” McMahon wrote in a Monday order.

McMahon referred to a motion by the defendants, Actavis and its wholly owned subsidiary Forest Laboratories, which have faced numerous suits over allegations it illegally engaged in an anti-competitive scheme to block generic competition to its Namenda Alzheimer's drug.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Go To Lexis →

Not a Lexis Subscriber?
Subscribe Now

Go To Bloomberg Law →

Not a Bloomberg Law Subscriber?
Subscribe Now

NOT FOR REPRINT